T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma

2015196 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Cancer Cell

Volume 28, Issue 5, pp. 638-652

Field-Weighted Citation Impact: 9.64